THE D MAJOR GROUP for ALLERGAN INC (FORMERLY ACTAVIS INC )
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Monitor issues concerning bioequivalence standards for pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Copyright/Patent/Trademark CPT
Advocate for Inter Partes Review (IPR) reform concerning pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Comt. |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Taxation/Internal Revenue Code TAX
Monitor technical corrections to H.R. 1, the Tax Cuts and Jobs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Health Issues HCR
Advocate for voluntary best practices related to pharmaceutical pricing. Engage with policymakers on Medicare Part D prescription drug benefit as related to HR 1892, the Bipartisan Budget Act of 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Analyst for the Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for the House Republican Conference |
Budget/Appropriations BUD
Advocate for FDA oversight of compounded medicines as related to the HR 1625, the Consolidated Appropriations Act of 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.